Quotes for DanCann Pharma A/S
Right Now
- +/-
- %
- Latest
- High
- Low
- Volume
- Turnover ()
- Time (Latest trade)
Board
CEO
- Jeppe Krog Rasmussen
Chairperson of the Board
- Carsten Trads
Board
- Jeppe Krog Rasmussen
- Christian Carlsen
DanCann Pharma A/S
DanCann Pharma was founded in 2018 and is a Danish pharmaceutical company. DanCann Pharma focuses on discovering, developing, manufacturing, and commercializing cannabinoid therapeutics in a broad range of disease areas. The company makes prescription (Rx-pharmaceuticals) and over-the-counter (OTC) pharmaceuticals mainly focused on pain patients with alternative needs and management to handle their illness, covered by the Danish Pilot Programme for medical cannabis.
News
- Minutes of extraordinary general meeting
- DanCann Pharma A/S: Calls for an Extraordinary General Meeting regarding New Authorizations and Reduction of Share Capital in Preparation for Reverse Stock Split
- NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S
- DanCann Pharma A/S: Number of Reported Suspected Adverse Reactions Drops by Two-Thirds in 2023 Despite 72% Growth in the Medicinal Cannabis Pilot Programme
- DanCann Pharma A/S: Quarterly CEO Reflection
News agencies
- Finwire: Dancann Pharma vänder till positiv ebitda, höjer helårsprognosen
- Finwire: Dancann Pharmas företrädesemission tecknad till 56,7 procent inräknat för garanter
- Finwire: Dancann Pharma förväntar sig försäljningsintäkter på 10-11 miljoner danska kronor 2024
- Finwire: DanCann Pharma ser positiv påverkan av ny tysk cannabislag
- Finwire: Dancann Pharma ansöker om godkännande för två nya läkemedel
Analysis
- Carlsquare: Dancann Pharma Kv2 2022: Företrädesemission för att nå Break-even - Carlsquare
- Carlsquare: Dancann Pharma: Bygger pipeline inför lansering - Carlsquare
- Carlsquare: Dancann Pharma: Stärker framtida pipeline med minst 37 miljoner kronor - Carlsquare
- Carlsquare: Dancann Pharma: Startskottet på ny era? - Carlsquare
- Carlsquare: Dancann Pharma: Ljusare utsikter än någonsin tidigare - Carlsquare
Largest Owners
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Nordic Growth Opportunities 2 | 41,30 | 41,30 | 2024-01-10 |
| Sellers of CannGros ApS | 7,85 | 7,85 | 2021-10-05 |
| Alexander Schoeneck | 6,21 | 6,21 | 2022-06-30 |
| Futur Pension | 5,56 | 5,56 | 2021-09-30 |
| Jeppe Krog Rasmussen | 4,18 | 4,18 | 2023-11-30 |
| Morten Martinsen | 1,41 | 1,41 | 2021-12-30 |
| Hansen & Nytoft Invest Aps | 1,34 | 1,34 | 2021-08-19 |
| Tue Østergaard | 1,28 | 1,28 | 2022-12-31 |
| Vavi Invest Aps | 0,88 | 0,88 | 2021-08-19 |
| John Frellsen | 0,60 | 0,60 | 2021-07-26 |
Holdings by Modular Finance AB. Compiled and processed data from various sources, including VP Securities, Morningstar and The Danish Financial Supervisory Authority (Finanstilsynet)
Insider trading
*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority
Key Numbers
*Compiled data from Millistream
Upcoming reports
-
2024-11-29 Delårsrapport 2024-Q3
Annual reports, prospectus etc.
- 2024-05-24 Memorandum 2024
- 2024-05-15 Annual Report 2023
- 2023-05-12 Annual Report 2022
- 2022-11-04 Prospectus supplement 2022
- 2022-10-24 Prospectus 2022
- 2022-04-13 Annual Report 2021
- Show More
- 2022-04-13 Auditors report 2021
- 2021-04-07 Annual Report 2020
- 2020-10-09 Teaser SE 2020
- 2020-10-09 Teaser DK 2020
- 2020-10-02 Prospekt 2020
- Close